Cost vs. Quality: The Debate on Generic Medicines
Government-run Jan Aushadhi Kendras and chains like Generic Aadhaar offer medicines at a fraction of market prices, but pharma giants warn of quality risks. So, why is the All India Drug Action Network (AIDAN) advocating for the promotion of generic medicines despite quality concerns? How do pharmacy chains like…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like The Morning Brief →
Indian pharma: lofty aims in the midst of chaos
The Jan Aushadhi Revolution?
Why Indian Pharma struggles with quality control
Overhauling drugs law, Maha's new bike taxi rules, and Tata Sons' chairman
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.